Cargando…

Effects of the cannabinoid CB(1) receptor antagonist rimonabant on distinct measures of impulsive behavior in rats

RATIONALE: Pathological impulsivity is a prominent feature in several psychiatric disorders, but detailed understanding of the specific neuronal processes underlying impulsive behavior is as yet lacking. OBJECTIVES: As recent findings have suggested involvement of the brain cannabinoid system in imp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pattij, Tommy, Janssen, Mieke C. W., Schepers, Inga, González-Cuevas, Gustavo, de Vries, Taco J., Schoffelmeer, Anton N. M.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2007
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1915592/ https://www.ncbi.nlm.nih.gov/pubmed/17387457 http://dx.doi.org/10.1007/s00213-007-0773-4

Ejemplares similares

Acute effects of morphine on distinct forms of impulsive behavior in rats
por: Pattij, Tommy, et al.
Publicado: (2009)

On the Role of Cannabinoid CB1- and μ-Opioid Receptors in Motor Impulsivity
por: Wiskerke, Joost, et al.
Publicado: (2012)

Cannabinoid CB1 Receptor Activation Mediates the Opposing Effects of Amphetamine on Impulsive Action and Impulsive Choice
por: Wiskerke, Joost, et al.
Publicado: (2011)

Unidirectional relationship between heroin self-administration and impulsive decision-making in rats
por: Schippers, Maria C., et al.
Publicado: (2011)

Dissociable effects of cocaine and yohimbine on impulsive action and relapse to cocaine seeking
por: Broos, Nienke, et al.
Publicado: (2017)

Varenicline attenuates cue-induced relapse to alcohol, but not nicotine seeking, while reducing inhibitory response control
por: Wouda, Jelte A., et al.
Publicado: (2011)

On the improvement of inhibitory response control and visuospatial attention by indirect and direct adrenoceptor agonists
por: Pattij, Tommy, et al.
Publicado: (2011)

Relationships between glucose, energy intake and dietary composition in obese adults with type 2 diabetes receiving the cannabinoid 1 (CB1) receptor antagonist, rimonabant
por: Heppenstall, Charlotte, et al.
Publicado: (2012)

The Relationship between Impulsive Choice and Impulsive Action: A Cross-Species Translational Study
por: Broos, Nienke, et al.
Publicado: (2012)

CB1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced renal injury in rats
por: Zhao, Li, et al.
Publicado: (2021)

Context-dependent effects of the CB1 receptor antagonist rimonabant on morphine-induced behavioral sensitization in female mice
por: Marinho, Eduardo A. V., et al.
Publicado: (2023)

Differential effects of the pharmacological stressor yohimbine on impulsive decision making and response inhibition
por: Schippers, M. C., et al.
Publicado: (2016)

CB1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced bone metabolism disorder and destruction in rats
por: Dou, Zhan-jun, et al.
Publicado: (2020)

A high working memory load prior to memory retrieval reduces craving in non-treatment seeking problem drinkers
por: Kaag, Anne Marije, et al.
Publicado: (2017)

Hepatic targeting of the centrally active cannabinoid 1 receptor (CB(1)R) blocker rimonabant via PLGA nanoparticles for treating fatty liver disease and diabetes
por: Hirsch, Shira, et al.
Publicado: (2023)

Deep Brain Stimulation of the Nucleus Accumbens Core Affects Trait Impulsivity in a Baseline-Dependent Manner
por: Schippers, Maria C., et al.
Publicado: (2017)

SERENADE: The Study Evaluating Rimonabant Efficacy in Drug-Naive Diabetic Patients : Effects of monotherapy with rimonabant, the first selective CB(1) receptor antagonist, on glycemic control, body weight, and lipid profile in drug-naive type 2 diabetes
por: Rosenstock, Julio, et al.
Publicado: (2008)

The CB(1) Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability
por: Gueye, Aliou B., et al.
Publicado: (2016)

Cannabinoid(1) (CB-1) receptor antagonists: a molecular approach to treating acute cannabinoid overdose
por: Skolnick, Phil, et al.
Publicado: (2019)

An automated home-cage-based 5-choice serial reaction time task for rapid assessment of attention and impulsivity in rats
por: Bruinsma, B., et al.
Publicado: (2019)

Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors
por: Mollica, Adriano, et al.
Publicado: (2017)

PM288. Preclinical Evaluation of Neutral Cannabinoid CB1 Receptor Antagonists and Cannabinoid CB1 Receptor Negative Allosteric Modulators for Treating Drug Addiction
por: Gardner, Eliot L., et al.
Publicado: (2016)

Rimonabant-Based Compounds Bearing Hydrophobic Amino Acid Derivatives as Cannabinoid Receptor Subtype 1 Ligands
por: Dvorácskó, Szabolcs, et al.
Publicado: (2023)

Functional Selectivity of a Biased Cannabinoid-1 Receptor (CB(1)R) Antagonist
por: Liu, Ziyi, et al.
Publicado: (2021)

Protocol for crystal structure determination of the antagonist-bound human cannabinoid receptor CB2
por: Shen, Ling, et al.
Publicado: (2021)

Rimonabant for treating tobacco dependence
por: Steinberg, Michael B, et al.
Publicado: (2007)

Rimonabant: From RIO to Ban
por: Sam, Amir H., et al.
Publicado: (2011)

Rimonabant, Gastrointestinal Motility and Obesity
por: Sun, Yan, et al.
Publicado: (2012)

Rimonabant-induced depression in schizophrenia
por: Arasappa, Rashmi, et al.
Publicado: (2014)

Cannabinoid CB(1) and CB(2) Receptor Signaling and Bias
por: Ibsen, Mikkel Søes, et al.
Publicado: (2017)

CB1 Receptor-Dependent and Independent Induction of Lipolysis in Primary Rat Adipocytes by the Inverse Agonist Rimonabant (SR141716A)
por: Müller, Günter A., et al.
Publicado: (2020)

Cannabigerol Action at Cannabinoid CB(1) and CB(2) Receptors and at CB(1)–CB(2) Heteroreceptor Complexes
por: Navarro, Gemma, et al.
Publicado: (2018)

Neural Effects of Cannabinoid CB1 Neutral Antagonist Tetrahydrocannabivarin on Food Reward and Aversion in Healthy Volunteers
por: Tudge, Luke, et al.
Publicado: (2015)

Expression and Function of Cannabinoid Receptors CB1 and CB2 and Their Cognate Cannabinoid Ligands in Murine Embryonic Stem Cells
por: Jiang, Shuxian, et al.
Publicado: (2007)

The Structure–Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation
por: Bow, Eric W., et al.
Publicado: (2016)

Cannabinoid CB1 receptors regulate salivation
por: Andreis, Kelsey, et al.
Publicado: (2022)

Voltage dependence of the cannabinoid CB1 receptor
por: Goldberger, Esty, et al.
Publicado: (2022)

Potential role of the endocannabinoid receptor antagonist rimonabant in the management of cardiometabolic risk: a narrative review of available data
por: Bronander, Kirk A, et al.
Publicado: (2007)

Structural basis of selective cannabinoid CB(2) receptor activation
por: Li, Xiaoting, et al.
Publicado: (2023)

Cannabinoid Receptors CB1 and CB2 Modulate the Electroretinographic Waves in Vervet Monkeys
por: Bouskila, Joseph, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jtugk02phlqdvrvubi29tdvre4